ResearchThe Present and the Future of Risk Stratification for and Prevention of Sudden Cardiac Death: A Heart Rhythm Society Think Tank Meeting
ResearchLactate Dehydrogenase and Outcomes in Patients With HF and Reduced Ejection Fraction: Insights From GALACTIC-HF
ResearchSerum magnesium and outcomes in heart failure with reduced ejection fraction: the GALACTIC-HF trial
ResearchResidual Risk Despite Quadruple Medical Therapy for Men vs Women Hospitalized for Heart Failure With Reduced Ejection Fraction
ResearchOne-Year Outcomes in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Prescribed Quadruple Medical Therapy at Discharge
Mar 29, 2026Journal ArticleClinical Characteristics, Treatment Patterns, and Outcomes of Patients with Worsening Heart Failure Managed with Outpatient Intravenous Diuretics.Written by 1 Roon author & 9 others Via Journal of Cardiac Failure
ResearchMitral regurgitation in patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF
ResearchEffect of the cardiac myosin activator omecamtiv mecarbil on ventricular arrhythmias, cardiac arrest, and sudden death in heart failure with reduced ejection fraction: the GALACTIC-HF trial
ResearchDipstick proteinuria and outcomes in patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF
ResearchSafety and Feasibility of the eLymTM System for Interstitial Decongestion in Acute Decompensated Heart Failure: Primary results of the DELTA-HF trial
ResearchMedian Survival Among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction Prescribed Quadruple Medical Therapy
Jan 1, 2025EditorialOn Hurricanes and Resilience.Written by 1 Roon author Via Journal of Cardiac Failure